Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02279433
Title A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors AnHeart Therapeutics Inc.
Indications

Advanced Solid Tumor

neuroendocrine tumor

colorectal cancer

lung non-small cell carcinoma

pulmonary large cell neuroendocrine carcinoma

Therapies

Taletrectinib

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST